Cost-effectiveness analysis of neoadjuvant docetaxel plus androgen deprivation therapy before radical prostatectomy in high-risk localized prostate cancer.
Saved in:
| Title: | Cost-effectiveness analysis of neoadjuvant docetaxel plus androgen deprivation therapy before radical prostatectomy in high-risk localized prostate cancer. |
|---|---|
| Authors: | Liu Q; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China., Wang Y; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China., Yuan W; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China., Chen J; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China., Tian F; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China., Zhan M; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China., Guo M; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China. |
| Source: | Frontiers in public health [Front Public Health] 2026 May 05; Vol. 14, pp. 1786699. Date of Electronic Publication: 2026 May 05 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet ISSN: 2296-2565 (Electronic) Linking ISSN: 22962565 NLM ISO Abbreviation: Front Public Health Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2296-2565 |
|---|---|
| DOI: | 10.3389/fpubh.2026.1786699 |
